IP Library › Assignment 047115/0102
Patent Assignment
Reel/Frame 047115/0102

Assignment of Assignor's Interest

Recorded: 2018-09-20 Pages: 83
Assignor
OREXIGEN THERAPEUTICS, INC.
Executed: 2018-07-13
Assignee
NALPROPION PHARMACEUTICALS, INC.
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
Covered Properties (5)
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent: 8,969,371 →
Application: 14/322,810 →
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent: 9,119,850 →
Application: 14/635,518 →
Publication: US 2015/0182524
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent: 9,801,875 →
Application: 14/839,792 →
Publication: US 2015/0366860
Compositions and Methods for Reducing Major Adverse Cardiovascular Events
Application: 15/101,878 →
Publication: US 2016/0310485
Compositions and Methods for Weight Loss in at Risk Patient Populations
Application: 15/725,830 →
Publication: US 2018/0243288
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 15, 2014
From: KLASSEN, PRESTON; TAYLOR, KRISTIN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 033953/0347 →
Security Agreement Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest Mar 22, 2017
From: KLASSEN, PRESTON; TAYLOR, KRISTIN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041688/0934 →
Assignment of Assignor's Interest Mar 28, 2017
From: KLASSEN, PRESTON; TAYLOR, KRISTIN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041765/0767 →
Assignment of Assignor's Interest Jan 9, 2018
From: KLASSEN, PRESTON; TAYLOR, KRISTIN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 044578/0150 →
Security Interest Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Security Interest May 6, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 049092/0156 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050520/0149 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →